Author: Peter Mansell

US-based contract research organisation Ockham has boosted its global scale and its specialist capabilities in cancer trials by acquiring Nexus Oncology, a niche CRO that operates across Europe, North America and Australasia from headquarters in Roslin, Scotland. 

CROMSOURCE, the international contract research organisation (CRO) formed last April from the acquisition of Belgium’s MSOURCE by Verona, Italy-based CROM, has added early-phase capabilities to its range of services through an “innovative private-public deal” with Centro Ricerche Cliniche di Verona (CRC).

A newly patented computer system developed at a National CancerInstitute-designated Comprehensive CancerCenter in the US could refineand streamline oncology trials by matching registered patients’ molecularprofiles to suitably targeted drug candidates.

PPD has formed a strategic alliance with NHS Research Scotland (NRS) aimed at streamlining procedures and boosting patient recruitment for clinical trials in the region.

With Asia continuing to provide fresh sources of business growth, investment capital, patient recruitment and R&D capabilities for the biopharmaceutical industry, Quintiles has launched two new services to help clients navigate the complexities of developing and commercialising drugs in the region.